COA At-a-Glance
Evidence of cognitive interviewing of draft instrument in target patient population
Evidence of internal consistency
Evidence of test-retest or inter-rater reliability
Evidence of concurrent validity
Evidence of known-groups validity
Evidence of ability to detect change over time
Evidence of responder thresholds
Inclusion of the COA in product labelling
- Overview
- Content Validity
- Reliability
- Validity
- Ability to Detect Change
- Responder Thresholds
- Reference(s) of development / validation
- Other references
- Inclusion of the COA in product labelling
- Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
- Existence of Scoring / Interpretation / User Manual
- Original language and translations
- References of translations
- Authors and contact information
- Condition of use: copyright
- Website
- Review copy
Overview
Instrument Name: Neonatal Infant Acute Pain Assessment Scale
Abbreviation: NIAPAS
Points for Consideration:
None
Description of Tool:
The Neonatal Infant Acute Pain Assessment Scale (NIAPAS) is an 8-item ObsRO developed for infants in the neonatal intensive care unit. The NIAPAS includes five behavioral and three physiological indicators rated for each neonate on a 2 (0,1), 3 (0,1,2) or 4 (0,1,2,3)-level scale. Higher scores represent higher pain.
Other Related Tools (if applicable):
None identified
Minimum Qualification Required by COA Administrator: PhD or MA
Comment:
None
Year: 2014
Objective of Development:
To develop a multidimensional scale sensitive to the needs of infants in neonatal intensive care units.
Population of Development: Age range (therapeutic indication):
Age range: 23-42 weeks gestational age (Pain)
Pediatric Population(s) in which COA has been used:
Neonates undergoing painful procedures
COA type: ObsRO
Number of Items 8
Mode of Administration: Clinician-rated
Data Collection Mode: No information
Time for Completion: On average 61.4s (range: 5-300s, SD 70.7)
Response Scales: 2, 3, or 4-point scale (0, 1; or 0, 1, 2; or 0, 1, 2, 3)
Summary of Scoring:
Available scores: Possible total score of 18.
Weighting: No
Score Interpretation: Higher score = Higher pain
Content Validity
Evidence of Literature Review: None identified
Evidence of Instrument Review: None identified
Evidence of Clinical or Expert Input: Yes
Evidence of concept elicitation in target patient population: None identified
Evidence of a Saturation Grid: None identified
Evidence for Selection of Data Collection Method: None identified
Recall/Observation Period: Present time
Evidence for Selection of Reponse Options: None identified
Evidence of cognitive interviewing of draft instrument in target patient population: None identified
Evidence of Preliminary Scoring of Items and Domains: None identified
Evidence related to respondent and administrator burden: None identified
Evidence of a Conceptual Framework: None identified
Evidence of an item-tracking matrix: None identified
Evidence related to item selection: None identified
Evidence of re-testing the final version: Yes
Reliability
Internal consistency (Cronbach's alpha): Yes
Evidence of internal consistency: Pölkki T (2014) - Method: Cronbach's alpha - Results: 0.73 - Population/Disease: Neonates (born between 23 and 42 weeks gestational age) who were undergoing 60 painful procedures; n=34
Test-retest Reliability (ICC):
None identified
Inter-rater/ inter-interviewer reliability (kappa):
Pölkki T (2014)
Interrater reliability
- Correlation Coefficient used: Not stated. Reliability ranged from 0.991 to 0.997; p Not stated for all results
- Population/Disease: n=34 neonates (born between 23 and 42 weeks gestational age) who were undergoing 60 painful procedures.
Pölkki T (2014)
Intrarater reliability
- Correlation Coefficient used: Not stated. Reliability ranged from 0.997 to 1.00
- Population/Disease: n=34 neonates (born between 23 and 42 weeks gestational age) who were undergoing 60 painful procedures.
Evidence of test-retest or inter-rater reliability: Yes
Validity
Concurrent validity (convergent, divergent):
Pölkki T (2014)
Convergent validity
- Correlation coefficient used: Pearson's r
- Measures: NIAPAS; Neonatal Infant Pain Score (NIPS)
- Timepoints: 1 minute before; during; 1 min after painful procedure (heel lance or tracheal suctioning)
- Results:
Before: r=0.751, p<0.001
During: r=0.873, p<0.001
After: r=0.804, p<0.001
- Population/Disease: Neonates (born between 23 and 42 weeks gestational age) who were undergoing 60 painful procedures; n=34
Known-group validity:
None identified
Evidence of Translatability Assessment: None identified
Evidence related to missing data: None identified
Evidence for Selection of Recall Period: None identified
Evidence of Administration Instructions and Training Provided: Yes
Evidence of concurrent validity: Yes
Evidence of known-groups validity: None identified
Evidence of ability to detect change over time: None identified
Ability to Detect Change
Ability to detect change (Responsiveness):
None identified
Responder Thresholds
Responder Thresholds:
None identified
Evidence of responder thresholds: None identified
Reference(s) of development / validation
Pölkki, T., Korhonen, A., Axelin, A., Saarela, T., & Laukkala, H. (2014). Development and preliminary validation of the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). International journal of nursing studies, 51(12), 1585–1594. Full Text Article: https://pubmed.ncbi.nlm.nih.gov/24815773/
Other references
None identified
Inclusion of the COA in product labelling
None identified
Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
None identified
Existence of Scoring / Interpretation / User Manual
Yes
Original language and translations
Original language: English
Translation (PROQOLID): 1 translation (not specified)
References of translations
None identified
Condition of use: copyright
None identified
Website
None identified
Review copy
None identified